{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:17:05Z","timestamp":1793477825806,"version":"4.5.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Interleukin-1 receptor-associated kinase 1 (IRAK1), an active serine\/threonine kinase, is an indispensable mediator of inflammatory responses and innate immunity. Emerging evidence has highlighted the oncogenic role of IRAK1 in tumors. However, the role of IRAK1 in gastric cancer (GC) progression remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      IRAK1 expression levels in patients with GC at Peking Union Medical College Hospital were assessed by Western blotting, quantitative real-time polymerase chain reaction, and immunohistochemistry. To elucidate the role of IRAK1 in GC pathogenesis, we established GC cells with clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) mediated\n                      <jats:italic toggle=\"yes\">IRAK1<\/jats:italic>\n                      knockout and lentiviral vector-mediated IRAK1 overexpression and subsequently conducted\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      experiments. Additionally, we assessed the effect of IRAK1 expression levels in GC cells on the M2 polarization of tumor-associated macrophages (TAMs) via a Transwell coculture system. Functional assays were subsequently carried out to determine whether IRAK1 regulates the proliferation, invasion, and epithelial-mesenchymal transition (EMT) of GC cells through the induction of TAM M2 polarization and to clarify the associated regulatory mechanisms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      IRAK1 expression was progressively increased during GC progression. Clinicopathological feature analysis revealed that high IRAK1 expression predicted poor survival outcomes.\n                      <jats:italic toggle=\"yes\">In vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      experiments revealed that IRAK1 was highly expressed in GC cells and facilitated the proliferation, migration, invasion, and EMT of GC cells via the phosphatidylinositol 3-kinase\/protein kinase B\/mammalian target of rapamycin (PI3K\/AKT\/mTOR) pathway. More interestingly, IRAK1 affected the malignant biological behavior of GC cells by inducing M2-like polarization of macrophages. Mechanistically, coculturing M0 macrophages with\n                      <jats:italic toggle=\"yes\">IRAK1<\/jats:italic>\n                      -knockout GC cells suppressed interleukin (IL)-8 secretion, thereby inhibiting Janus kinase 2\/signal transducer and activator of transcription 3 (JAK2\/STAT3) pathway activation in TAMs. Inactivation of the JAK2\/STAT3 pathway suppressed the M2 polarization of TAMs, ultimately inhibiting GC progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>IRAK1 influences the malignant biological behavior of GC cells by activating the PI3K\/AKT\/mTOR pathway and inducing the M2-like polarization of macrophages via the IL-8\/JAK2\/STAT3 pathway in TAMs. Our findings provide a novel diagnostic biomarker and a promising therapeutic strategy for GC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003944","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:00:10Z","timestamp":1766390410000},"page":"265-281","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["IRAK1 promotes gastric cancer progression by activating the PI3K\/AKT\/mTOR pathway and inducing the M2 polarization of tumor-associated macrophages"],"prefix":"10.1097","volume":"139","author":[{"given":"Ju","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlu","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiming","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"R1-20260407","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(16)32226-7","article-title":"The challenge of screening for early gastric cancer in China","volume":"388","author":"Zong","year":"2016","journal-title":"Lancet"},{"key":"R2-20260407","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.crad.2021.01.001","article-title":"Opportunities in cancer imaging: A review of oesophageal, gastric and colorectal malignancies","volume":"76","author":"Foley","year":"2021","journal-title":"Clin Radiol"},{"key":"R3-20260407","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/cac2.12193","article-title":"The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021","volume":"41","author":"Wang","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"R4-20260407","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamasurg.2022.0182","article-title":"Surgical management of gastric cancer: A review","volume":"157","author":"Li","year":"2022","journal-title":"JAMA Surg"},{"key":"R5-20260407","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/annonc\/mdx051","article-title":"New agents on the horizon in gastric cancer","volume":"28","author":"Lordick","year":"2017","journal-title":"Ann Oncol"},{"key":"R6-20260407","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol Ther"},{"key":"R7-20260407","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: New opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"key":"R8-20260407","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189166","article-title":"Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for cancer therapy","volume":"1879","author":"Jia","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R9-20260407","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: A spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"R10-20260407","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: Biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R11-20260407","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102015","article-title":"The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target","volume":"86","author":"Gambardella","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"R12-20260407","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"R13-20260407","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105576","article-title":"A sweet spot for macrophages: Focusing on polarization","volume":"167","author":"Yang","year":"2021","journal-title":"Pharmacol Res"},{"key":"R14-20260407","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: An accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J Biomed Sci"},{"key":"R15-20260407","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00018-016-2166-5","article-title":"Tumor-associated macrophages and anti-tumor therapies: Complex links","volume":"73","author":"Belgiovine","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"R16-20260407","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2017.07.007","article-title":"Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis","volume":"147","author":"Yuan","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R17-20260407","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.oraloncology.2019.04.019","article-title":"Prognostic significance of CD68(+) and CD163(+) tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis","volume":"93","author":"Troiano","year":"2019","journal-title":"Oral Oncol"},{"key":"R18-20260407","article-title":"Prognostic value of tumor-associated macrophages in clear cell renal cell carcinoma: A systematic review and meta-analysis","volume":"11","author":"Shen","year":"2021","journal-title":"Front Oncol"},{"key":"R19-20260407","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bcp.2010.06.020","article-title":"The interleukin-1 receptor-associated kinases: Critical regulators of innate immune signalling","volume":"80","author":"Flannery","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"R20-20260407","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.3390\/molecules29102226","article-title":"Recent advances in IRAK1: Pharmacological and therapeutic aspects","volume":"29","author":"Kim","year":"2024","journal-title":"Molecules"},{"key":"R21-20260407","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12943-021-01460-1","article-title":"IRAK1-regulated IFN-gamma signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies","volume":"20","author":"Cai","year":"2021","journal-title":"Mol Cancer"},{"key":"R22-20260407","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s43032-021-00789-8","article-title":"MiR-192-5p-modified tumor-associated macrophages-derived exosome suppressed endometrial cancer progression through targeting IRAK1\/NF-\u03baB signaling","volume":"29","author":"Wang","year":"2022","journal-title":"Reprod Sci"},{"key":"R23-20260407","doi-asserted-by":"crossref","first-page":"25299","DOI":"10.1021\/acsomega.1c03081","article-title":"1,4-naphthoquinone is a potent inhibitor of IRAK1 kinases and the production of inflammatory cytokines in THP-1\u202fdifferentiated macrophages","volume":"6","author":"Mahmoud","year":"2021","journal-title":"ACS Omega"},{"key":"R24-20260407","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bcp.2017.08.019","article-title":"A Jak2-selective inhibitor potently reverses the immune suppression by modulating the tumor microenvironment for cancer immunotherapy","volume":"145","author":"He","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"R25-20260407","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12967-025-06469-4","article-title":"PD-1 regulates the anti-tumor immune function of macrophages through JAK2-STAT3\u202fsignaling pathway in colorectal cancer tumor microenvironment","volume":"23","author":"Jiang","year":"2025","journal-title":"J Transl Med"},{"key":"R26-20260407","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12935-024-03453-8","article-title":"Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1\/JAK2\/STAT3 pathway in gastric cancer","volume":"24","author":"Su","year":"2024","journal-title":"Cancer Cell Int"},{"key":"R27-20260407","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R28-20260407","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"R29-20260407","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.semcancer.2021.12.004","article-title":"Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer","volume":"86","author":"Zeng","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R30-20260407","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathmechdis-032221-115501","article-title":"Innate immunity and cancer pathophysiology","volume":"17","author":"Maiorino","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"R31-20260407","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/bjc.2014.513","article-title":"IRAK signalling in cancer","volume":"112","author":"Rhyasen","year":"2015","journal-title":"Br J Cancer"},{"key":"R32-20260407","doi-asserted-by":"crossref","first-page":"40653","DOI":"10.1074\/jbc.M402666200","article-title":"The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling","volume":"279","author":"Lye","year":"2004","journal-title":"J Biol Chem"},{"key":"R33-20260407","doi-asserted-by":"crossref","first-page":"8746","DOI":"10.1038\/ncomms9746","article-title":"IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel","volume":"6","author":"Wee","year":"2015","journal-title":"Nat Commun"},{"key":"R34-20260407","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13046-016-0413-0","article-title":"Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma","volume":"35","author":"Li","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"R35-20260407","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-024-06736-0","article-title":"The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1\u202fmRNA through the MAPK pathway","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis"},{"key":"R36-20260407","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1038\/s41375-018-0112-2","article-title":"Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes","volume":"32","author":"Hosseini","year":"2018","journal-title":"Leukemia"},{"key":"R37-20260407","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature09121","article-title":"Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR\/IL-1R signalling","volume":"465","author":"Lin","year":"2010","journal-title":"Nature"},{"key":"R38-20260407","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88\u202fmutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"R39-20260407","doi-asserted-by":"crossref","first-page":"E4762","DOI":"10.1073\/pnas.1405423111","article-title":"Interleukin 1 receptor-associated kinase 1 (IRAK1)\u202fmutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma","volume":"111","author":"Yang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-20260407","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"R41-20260407","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s11427-023-2499-2","article-title":"Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K\/Akt\/mTOR pathway","volume":"67","author":"Ganesan","year":"2024","journal-title":"Sci China Life Sci"},{"key":"R42-20260407","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101063","article-title":"Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer","volume":"73","author":"Ou","year":"2024","journal-title":"Drug Resist Updat"},{"key":"R43-20260407","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13046-019-1043-0","article-title":"FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis","volume":"38","author":"Wei","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"R44-20260407","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/his.12607","article-title":"High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer","volume":"66","author":"Tiainen","year":"2015","journal-title":"Histopathology"},{"key":"R45-20260407","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1097\/SLA.0000000000004037","article-title":"Poor clinical outcomes and immunoevasive contexture in intratumoral IL-10-producing macrophages enriched gastric cancer patients","volume":"275","author":"Zhang","year":"2022","journal-title":"Ann Surg"},{"key":"R46-20260407","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/nan.12428","article-title":"Tumour-associated microglia\/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype","volume":"44","author":"Sorensen","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R47-20260407","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aab2191","article-title":"Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use","volume":"9","author":"Sun","year":"2016","journal-title":"Sci Signal"},{"key":"R48-20260407","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103209","article-title":"Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression","volume":"74","author":"Gu","year":"2024","journal-title":"Redox Biol"},{"key":"R49-20260407","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41419-020-02926-8","article-title":"M2\u202fmacrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2","volume":"11","author":"Dong","year":"2020","journal-title":"Cell Death Dis"},{"key":"R50-20260407","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","article-title":"Tumor-recruited M2\u202fmacrophages promote gastric and breast cancer metastasis via M2\u202fmacrophage-secreted CHI3L1 protein","volume":"10","author":"Chen","year":"2017","journal-title":"J Hematol Oncol"},{"key":"R51-20260407","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mc.23268","article-title":"M2-like tumor-associated macrophages-secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating beta-catenin pathway in thyroid cancer","volume":"60","author":"Lv","year":"2021","journal-title":"Mol Carcinog"},{"key":"R52-20260407","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ymthe.2020.11.024","article-title":"M2\u202fmacrophage-derived exosomes promote angiogenesis and growth of pancreatic ductal adenocarcinoma by targeting E2F2","volume":"29","author":"Yang","year":"2021","journal-title":"Mol Ther"},{"key":"R53-20260407","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13046-022-02366-6","article-title":"A positive feedback loop between gastric cancer cells and tumor-associated macrophage induces malignancy progression","volume":"41","author":"Piao","year":"2022","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:01:33Z","timestamp":1775592093000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003944","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2025-08-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}